Skip to content
drillr.ai

ACH

Accendra Health, Inc.

NYSE · USHealthcareMedical - Distribution
$3.32-4.32%

Price as of Jul 20, 2026

ACH news

Accendra Health, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations

    Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced the expiration and final results of the previously announced offers to exchange (the “Exchange Offers”) any and all of the Company’s outstanding 4.500% Senior Notes due 2029 (the “2029 Notes”) and 6.625% Senior Notes due 2030 (the “2030 Notes” and, together with the 2029 Notes, the “Existing Notes”). As of 5:00 P.M., New York City time, on

    Business Wire ·

  2. Accendra Health Announces Early Results of Offers and Consent Solicitations

    Accendra Health Announces Early Results of Offers and Consent Solicitations Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced the early results of the previously announced offers to exchange (the “Exchange Offers”) any and all of the Company’s outstanding 4.500% Senior Notes due 2029 (the “2029 Notes”) and 6.625% Senior Notes due 2030 (the “2030 Notes” and, together with the 2029 Notes, the “Existing Notes”). Eligible Holders of 2029 Notes that participate in the New Money Notes

    Business Wire ·

  3. Accendra Health Announces Offers and Consent Solicitations

    Accendra Health Announces Offers and Consent Solicitations Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced that it has commenced an offer to exchange (the “Exchange Offers”) any and all of the Company’s outstanding 4.500% Senior Notes due 2029 (the “2029 Notes”) and 6.625% Senior Notes due 2030 (the “2030 Notes” and, together with the 2029 Notes, the “Existing Notes”). Eligible Holders of 2029 Notes that participate in the New Money Notes Issuance (as defined below) will be ab

    Business Wire ·

  4. Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction

    Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction Commitments in Place from Existing Creditors to Strengthen Balance Sheet, Extend Maturities, and Reduce Leverage Accendra Health, Inc. (NYSE: ACH) today reported financial results for the first quarter ended March 31, 2026, and announced a more than $1.5 billion comprehensive balance sheet optimization transaction with commitments from existing creditors that will str

    Business Wire ·

  5. Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call

    Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the first quarter of 2026 on Monday, May 11, 2026, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1

    Business Wire ·